211 The diuretic effect of steroids in pateints with heart failure: a rapid review, narrative synthesis and meta-analysis

Read full text
Authors: Madison Gill, Dionisius Ardiyanto, Hammad Buksh Ilahi, Alicia Pearson, Ibrahim Mahmoud, Sarah Greenley, Andrea Hilton, Lee Middleton, Jon Bishop, Miriam J Johnson, John GF Cleland, Andrew Clark
+2 more Maureen Twiddy, Joseph James Cuthbert
Cited by: 1

Abstract

Introduction Steroids may have a diuretic effect. It is unknown whether they are a useful treatment for venous congestion due to heart failure (HF). Methods A rapid systematic review was conducted following PRISMA guidelines (PROSPERO CRD420200620029). Medline and CENTRAL databases were searched for studies involving adult HF patients receiving steroid. Randomized and observational studies were included. For those data on which meta-analysis (MA) was possible, a random effects model was used to calculate Cohen’s D and unstandardised mean difference (UMD) for continuous variables, and odds and log odds ratios (OR) for categorical variables. Risk of bias was evaluated using ROB-2 and ROBINS-I tools. Results From an initial 4349 records, 17 observational studies, and 6 randomised controlled trials (RCT) involving 22,815 patients were included (table 1). Oral steroid was associated with greater weight loss (Cohen’s D 0.69 (0.11 – 1.27); P=0.02), although the absolute differences were small (UMD 0.94 kg (standard error = 0.51; P=0.06) (figure 1). Urine volume and natriuresis also tended to be greater with steroid treatment but no MA was possible. Treatment with steroid had no effect on renal function or electrolyte concentrations. Hyperglycaemia was the most common side effect (4-35%) with an OR of 11.19 ((3.22 – 38.90); P

Fields of Study & Subjects

Heart Failure Treatment and Management Cardiovascular and exercise physiology GDF15 and Related Biomarkers

Publication details

Journal / source
Heart Failure and Cardiomyopathy
Publisher
BMJ Publishing Group Ltd and British Cardiovascular Society
Pages
A114–A115
Publication date
1 June 2026